

Okomistin eye drops:
100 ml contain benzyldimethyl [3- (myristoylamino) propyl] ammonium chloride monohydrate (Miramistin, in terms of anhydrous substance) 0.01 g;
Excipients: sodium chloride, purified water;
in polymeric bottles of 5 and 10 ml (complete with a dropper cap); in a pack of cardboard 1 or 5 bottles.
Okomistin has an antiseptic effect.
acute and chronic conjunctivitis;
blepharoconjunctivitis;
keratitis;
keratouveuitis;
prevention of purulent-inflammatory complications in the pre- and postoperative periods, as well as in the treatment of injuries.
hypersensitivity to Okomistin;
pregnancy;
breastfeeding period;
children's age up to 18 years.
Allergic reactions are possible. In some cases, you may experience a feeling of light burning, discomfort, which passes on its own after 15–20 s and does not require discontinuation of the drug.
Okomistin used topically (in the conjunctival sac).
With the purpose of treatment, the drug Okomistin (eye drops) is instilled 1–2 drops 4–6 times daily before clinical recovery.
With the preventive purpose, the drug is instilled 1–2 drops 3 times a day for 2-3 days before the operation, as well as for 10–15 days after the operation.
Store in a cool and dark place, protected from light and moisture, at a temperature not higher than 25 ° C.